These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 35522562

  • 1. CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment.
    Skroblyn T, Joedicke JJ, Pfau M, Krüger K, Bourquin JP, Izraeli S, Eckert C, Höpken UE.
    J Pathol; 2022 Sep; 258(1):12-25. PubMed ID: 35522562
    [Abstract] [Full Text] [Related]

  • 2. Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis.
    Kato I, Niwa A, Heike T, Fujino H, Saito MK, Umeda K, Hiramatsu H, Ito M, Morita M, Nishinaka Y, Adachi S, Ishikawa F, Nakahata T.
    PLoS One; 2011 Sep; 6(11):e27042. PubMed ID: 22069486
    [Abstract] [Full Text] [Related]

  • 3. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
    Arnaud MP, Vallée A, Robert G, Bonneau J, Leroy C, Varin-Blank N, Rio AG, Troadec MB, Galibert MD, Gandemer V.
    Blood; 2015 Oct 08; 126(15):1802-12. PubMed ID: 26320102
    [Abstract] [Full Text] [Related]

  • 4. Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis.
    de Rooij B, Polak R, van den Berk LCJ, Stalpers F, Pieters R, den Boer ML.
    Haematologica; 2017 Oct 08; 102(10):e389-e393. PubMed ID: 28619846
    [No Abstract] [Full Text] [Related]

  • 5. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
    Crazzolara R, Kreczy A, Mann G, Heitger A, Eibl G, Fink FM, Möhle R, Meister B.
    Br J Haematol; 2001 Dec 08; 115(3):545-53. PubMed ID: 11736934
    [Abstract] [Full Text] [Related]

  • 6. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
    Peled A, Klein S, Beider K, Burger JA, Abraham M.
    Cytokine; 2018 Sep 08; 109():11-16. PubMed ID: 29903571
    [Abstract] [Full Text] [Related]

  • 7. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
    van den Berk LC, van der Veer A, Willemse ME, Theeuwes MJ, Luijendijk MW, Tong WH, van der Sluis IM, Pieters R, den Boer ML.
    Br J Haematol; 2014 Jul 08; 166(2):240-9. PubMed ID: 24697337
    [Abstract] [Full Text] [Related]

  • 8. Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents.
    Gilbert DC, Chandler I, McIntyre A, Goddard NC, Gabe R, Huddart RA, Shipley J.
    J Pathol; 2009 Jan 08; 217(1):94-102. PubMed ID: 18839394
    [Abstract] [Full Text] [Related]

  • 9. Profiling of Cxcl12 receptors, Cxcr4 and Cxcr7 in murine testis development and a spermatogenic depletion model indicates a role for Cxcr7 in controlling Cxcl12 activity.
    Westernströer B, Terwort N, Ehmcke J, Wistuba J, Schlatt S, Neuhaus N.
    PLoS One; 2014 Jan 08; 9(12):e112598. PubMed ID: 25460567
    [Abstract] [Full Text] [Related]

  • 10. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.
    Randhawa S, Cho BS, Ghosh D, Sivina M, Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M, Burger JA.
    Br J Haematol; 2016 Aug 08; 174(3):425-36. PubMed ID: 27071778
    [Abstract] [Full Text] [Related]

  • 11. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
    Juarez J, Dela Pena A, Baraz R, Hewson J, Khoo M, Cisterne A, Fricker S, Fujii N, Bradstock KF, Bendall LJ.
    Leukemia; 2007 Jun 08; 21(6):1249-57. PubMed ID: 17410186
    [Abstract] [Full Text] [Related]

  • 12. Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.
    Barbieri F, Bajetto A, Thellung S, Würth R, Florio T.
    Expert Opin Drug Discov; 2016 Nov 08; 11(11):1093-1109. PubMed ID: 27598329
    [Abstract] [Full Text] [Related]

  • 13. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
    Han AR, Lee JY, Kim HJ, Min WS, Park G, Kim SH.
    Oncol Rep; 2015 Dec 08; 34(6):2880-8. PubMed ID: 26398122
    [Abstract] [Full Text] [Related]

  • 14. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X, Guo H, Duan H, Yang Y, Meng J, Liu J, Wang C, Xu H.
    Sci Rep; 2015 Nov 05; 5():16228. PubMed ID: 26538086
    [Abstract] [Full Text] [Related]

  • 15. Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.
    Sison EA, McIntyre E, Magoon D, Brown P.
    Mol Cancer Res; 2013 Sep 05; 11(9):1004-16. PubMed ID: 23754844
    [Abstract] [Full Text] [Related]

  • 16. Targeting chemokines for acute lymphoblastic leukemia therapy.
    Hong Z, Wei Z, Xie T, Fu L, Sun J, Zhou F, Jamal M, Zhang Q, Shao L.
    J Hematol Oncol; 2021 Mar 20; 14(1):48. PubMed ID: 33743810
    [Abstract] [Full Text] [Related]

  • 17. [Infiltration of the testes in acute lymphoblastic leukemia in childhood--personal experience].
    Konstantinidis N, Gebauer E, Krstić R, Konstantinidis G.
    Med Pregl; 1996 Mar 20; 49(9-10):405-7. PubMed ID: 8999300
    [Abstract] [Full Text] [Related]

  • 18. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C, Lei X, Xiong L, Hu Z, Tang B.
    Cell Death Dis; 2021 Apr 29; 12(5):422. PubMed ID: 33927188
    [Abstract] [Full Text] [Related]

  • 19. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE, Chevassut T, Pepper CJ, Pepper AG.
    Br J Haematol; 2020 Jun 29; 189(5):815-825. PubMed ID: 32135579
    [Abstract] [Full Text] [Related]

  • 20. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
    Sison EA, Magoon D, Li L, Annesley CE, Rau RE, Small D, Brown P.
    Oncotarget; 2014 Oct 15; 5(19):8947-58. PubMed ID: 25333254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.